Long-term Results of Stellate Ganglion Block in Patients with Olfactory Dysfunction
The Korean Journal of Pain
;
: 57-61, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-40588
ABSTRACT
BACKGROUND:
Olfactory dysfunction, including anosmia and hyposmia is difficult to treat. Although the mechanism is not well known, stellate ganglion block (SGB) is used to treat olfactory dysfunction. There are no prior studies on the long-term effects of SGB on olfactory dysfunction. The purpose of this study was to evaluate the continuity of therapeutic effects and patient satisfaction with SGB treatment.METHODS:
This was a follow-up study carried out via a telephonic survey. The olfactory function of the patient was evaluated using a visual analog scale (VAS). We checked VAS three times VAS-I (pre-treatment VAS), VAS-A (post-treatment VAS), and VAS-C (VAS at follow up telephone survey). We divided the subjects into 2 groups according to their responsiveness to SGB the responsive (R group) and the unresponsive groups (UR group). Patient satisfaction was evaluated using a Likert scale.RESULTS:
Out of the 40 subjects, 37 responded to the telephone survey. In the UR group, there was difference in the olfactory function. However, in the R group, there were significant VAS differences; VAS-I was 9.6 +/- 0.7, VAS-A was 5.1 +/- 4.2, and VAS-C was 2.7 +/- 2.7 (P < 0.05). On the Likert scale, patient satisfaction was as follows grade 1, 17 patients (45.9%); grade 2, 6 patients (16.2%); grade 3, 6 patients (16.2%); and grade 4, 8 patients (21.6%).CONCLUSIONS:
SGB is a safe, long-lasting, and effective therapeutic modality for olfactory dysfunction treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Olfato
/
Ganglio Estrellado
/
Teléfono
/
Arginina Vasopresina
/
Estudios de Seguimiento
/
Satisfacción del Paciente
/
Trastornos del Olfato
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
The Korean Journal of Pain
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS